Index by author
Barisano, G.
- Adult BrainYou have accessSignal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast AgentG. Barisano, B. Bigjahan, S. Metting, S. Cen, L. Amezcua, A. Lerner, A.W. Toga and M. LawAmerican Journal of Neuroradiology August 2019, 40 (8) 1274-1281; DOI: https://doi.org/10.3174/ajnr.A6148
Battapady, H.
- Adult BrainOpen AccessWhite Matter Lesion Penumbra Shows Abnormalities on Structural and Physiologic MRIs in the Coronary Artery Risk Development in Young Adults CohortI.M. Nasrallah, M.-K. Hsieh, G. Erus, H. Battapady, S. Dolui, J.A. Detre, L.J. Launer, D.R. Jacobs, C. Davatzikos and R.N. BryanAmerican Journal of Neuroradiology August 2019, 40 (8) 1291-1298; DOI: https://doi.org/10.3174/ajnr.A6119
Benson, J.C.
- Head and Neck ImagingYou have accessPrevalence of Spontaneous Asymptomatic Facial Nerve Canal Meningoceles: A Retrospective ReviewJ.C. Benson, K. Krecke, J.R. Geske, J. Dey, M.L. Carlson, J. Van Gompel and J.I. LaneAmerican Journal of Neuroradiology August 2019, 40 (8) 1402-1405; DOI: https://doi.org/10.3174/ajnr.A6133
Berestov, V.
- FELLOWS' JOURNAL CLUBNeurointerventionYou have accessPosterior Fossa Dural Arteriovenous Fistulas with Subarachnoid Venous Drainage: Outcomes of Endovascular TreatmentL. Détraz, K. Orlov, V. Berestov, V. Borodetsky, A. Rouchaud, L.G. de Abreu Mattos and C. MounayerAmerican Journal of Neuroradiology August 2019, 40 (8) 1363-1368; DOI: https://doi.org/10.3174/ajnr.A6140
Twenty-six patients treated endovascularly for posterior fossa dural AVFs, type III, IV, or V, were included in this study. One hundred percent of the dural AVFs were occluded. A transarterial approach was performed in 23 dural AVFs; a combined transarterial and transvenous approach, in 2 dural AVFs; and a transvenous approach alone, in 1 dural AVF. The middle meningeal artery was the most common artery chosen to inject embolic liquid (12/26). Procedure-related morbidity was 15.4% at 24 hours, 7.7% at discharge, and 0% at 6 months. Procedure-related mortality was 0%. The authors conclude that endovascular treatment offers high occlusion rates for posterior fossa dural AVFs with low morbidity and mortality rates.
Bergendal, Å.
- Adult BrainYou have accessGadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple SclerosisY. Forslin, J. Martola, Å. Bergendal, S. Fredrikson, M.K. Wiberg and T. GranbergAmerican Journal of Neuroradiology August 2019, 40 (8) 1265-1273; DOI: https://doi.org/10.3174/ajnr.A6112
Berkowitz, B.A.
- Adult BrainOpen AccessManganese-Enhanced MRI of the Brain in Healthy VolunteersD.M. Sudarshana, G. Nair, J.T. Dwyer, B. Dewey, S.U. Steele, D.J. Suto, T. Wu, B.A. Berkowitz, A.P. Koretsky, I.C.M. Cortese and D.S. ReichAmerican Journal of Neuroradiology August 2019, 40 (8) 1309-1316; DOI: https://doi.org/10.3174/ajnr.A6152
Bigjahan, B.
- Adult BrainYou have accessSignal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast AgentG. Barisano, B. Bigjahan, S. Metting, S. Cen, L. Amezcua, A. Lerner, A.W. Toga and M. LawAmerican Journal of Neuroradiology August 2019, 40 (8) 1274-1281; DOI: https://doi.org/10.3174/ajnr.A6148
Borodetsky, V.
- FELLOWS' JOURNAL CLUBNeurointerventionYou have accessPosterior Fossa Dural Arteriovenous Fistulas with Subarachnoid Venous Drainage: Outcomes of Endovascular TreatmentL. Détraz, K. Orlov, V. Berestov, V. Borodetsky, A. Rouchaud, L.G. de Abreu Mattos and C. MounayerAmerican Journal of Neuroradiology August 2019, 40 (8) 1363-1368; DOI: https://doi.org/10.3174/ajnr.A6140
Twenty-six patients treated endovascularly for posterior fossa dural AVFs, type III, IV, or V, were included in this study. One hundred percent of the dural AVFs were occluded. A transarterial approach was performed in 23 dural AVFs; a combined transarterial and transvenous approach, in 2 dural AVFs; and a transvenous approach alone, in 1 dural AVF. The middle meningeal artery was the most common artery chosen to inject embolic liquid (12/26). Procedure-related morbidity was 15.4% at 24 hours, 7.7% at discharge, and 0% at 6 months. Procedure-related mortality was 0%. The authors conclude that endovascular treatment offers high occlusion rates for posterior fossa dural AVFs with low morbidity and mortality rates.
Boulouis, G.
- FELLOWS' JOURNAL CLUBNeurointerventionYou have accessDistal Balloon Angioplasty of Cerebral Vasospasm Decreases the Risk of Delayed Cerebral InfarctionM.-A. Labeyrie, S. Gaugain, G. Boulouis, A. Zetchi, J. Brami, J.-P. Saint-Maurice, V. Civelli, S. Froelich and E. HoudartAmerican Journal of Neuroradiology August 2019, 40 (8) 1342-1348; DOI: https://doi.org/10.3174/ajnr.A6124
A group of 392 patients was analyzed (160 before versus 232 after January 2015). Distal balloon angioplasty was associated with the following: higher rates of angioplasty (43% versus 27%) and intravenous milrinone (31% versus 9%); lower rates of postangioplasty delayed cerebral infarction (2.2% versus 7.5%) and new angioplasty (8% versus 19%) independent of the rate of patients treated by angioplasty and milrinone; and the same rates of stroke related to angioplasty (3.6% versus 3.1%), delayed cerebral infarction (7.7% versus 12.5%), mortality (10% versus 11%), and favorable outcome (79% versus 73%). The authors conclude that distal balloon angioplasty is safe and decreases the risk of delayed cerebral infarction and the recurrence of vasospasm compared with conventional angioplasty. It fails to show a clinical benefit possibly because of confounding changes in adjuvant therapies of vasospasm during the study period.
Brami, J.
- FELLOWS' JOURNAL CLUBNeurointerventionYou have accessDistal Balloon Angioplasty of Cerebral Vasospasm Decreases the Risk of Delayed Cerebral InfarctionM.-A. Labeyrie, S. Gaugain, G. Boulouis, A. Zetchi, J. Brami, J.-P. Saint-Maurice, V. Civelli, S. Froelich and E. HoudartAmerican Journal of Neuroradiology August 2019, 40 (8) 1342-1348; DOI: https://doi.org/10.3174/ajnr.A6124
A group of 392 patients was analyzed (160 before versus 232 after January 2015). Distal balloon angioplasty was associated with the following: higher rates of angioplasty (43% versus 27%) and intravenous milrinone (31% versus 9%); lower rates of postangioplasty delayed cerebral infarction (2.2% versus 7.5%) and new angioplasty (8% versus 19%) independent of the rate of patients treated by angioplasty and milrinone; and the same rates of stroke related to angioplasty (3.6% versus 3.1%), delayed cerebral infarction (7.7% versus 12.5%), mortality (10% versus 11%), and favorable outcome (79% versus 73%). The authors conclude that distal balloon angioplasty is safe and decreases the risk of delayed cerebral infarction and the recurrence of vasospasm compared with conventional angioplasty. It fails to show a clinical benefit possibly because of confounding changes in adjuvant therapies of vasospasm during the study period.